Tech Company Financing Transactions
Altis Labs Funding Round
Altis Labs closed a $25 million Series A venture capital round on 9/18/2026. Backers included OrbiMed, Qiming Venture Partners USA and Benchstrength.
Transaction Overview
Company Name
Announced On
9/18/2026
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
OrbiMed (Lead Investor)
Qiming Venture Partners USA (Lead Investor)
Proceeds Purpose
The company plans to use the capital to expand its AI models across additional cancer types, scale commercial deployment with global biopharmaceutical partners, and establish its AI endpoints as a new standard for oncology clinical trials.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
100 College St 150
Toronto, Ontario, M5G 1L5
CA
Toronto, Ontario, M5G 1L5
CA
Phone
Undisclosed
Website
Email Address
Overview
Altis Labs is the AI-powered computational imaging company advancing precision medicine. We believe that medical imaging, making up 90% of all healthcare data, is the richest source of clinical insight but is vastly underutilized due to 40-year-old reductionist interpretation guidelines. Trained on the world's largest proprietary cancer imaging database, our deep learning algorithms help quantify treatment effect beyond simplistic and discordant tumor size measurements.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Felix Lenschen
President
Sally Daub
Browse more venture capital transactions:
Prev: 9/18/2026: ElevenLabs venture capital transaction
Next: 9/18/2026: FIZE Medical venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs